Coronary artery fistulae and treatment in children
Kahraman Yakut1, N Kürşad Tokel1, Birgül Varan1
1Departments of Pediatric Cardiology, Başkent University Faculty of Medicine, Ankara, Turkey.
Insights
This study reviewed 56 patients with coronary artery fistulae (CAF), finding both transcatheter and surgical closures to be safe and effective treatments. Lifelong follow-up is recommended for all patients, regardless of treatment, due to potential complications.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Interventional Cardiology
Background:
- Coronary artery fistulae (CAF) are abnormal connections between coronary arteries and heart chambers or vessels.
- While often asymptomatic, significant shunting or symptoms necessitate intervention.
- Understanding optimal treatment timing and long-term outcomes is crucial.
Purpose of the Study:
- To review treatment strategies for coronary artery fistulae (CAF) in a pediatric cohort.
- To evaluate long-term complications associated with CAF.
- To determine the most appropriate age for CAF intervention.
Main Methods:
- Retrospective review of 56 patients diagnosed with CAF between 2000 and 2018.
- Analysis of patient demographics, origin and termination sites of fistulae, and treatment modalities.
- Assessment of early and late complications following transcatheter or surgical closure.
Main Results:
- The right coronary artery was the most common origin (RCA).
- Right ventricle and pulmonary artery were common termination sites.
- Transcatheter closure (10 patients) and surgical correction (5 patients) showed no deaths or late complications; early complications were infrequent.
Conclusions:
- Transcatheter closure is a safe and highly successful treatment for CAF.
- Surgical correction is also effective with low complication rates.
- Lifelong follow-up is essential for all patients with CAF, treated or untreated, due to potential long-term complications.
Background And Objectives:
In this study, we aimed to review the treatment options and long-term problems of patients who were diagnosed with coronary artery fistulae (CAF) in our institution. We also tried to determine the most appropriate time for treatment of this condition.
Method:
From 2000 to 2018, the medical records of 56 patients (33 males and 23 females) who had CAF diagnoses were retrospectively reviewed.
Results:
The mean age of the patients at the time of diagnosis was 3.9 ± 4.6 years (range, 1 month to 18 years) and the mean duration of the follow-up period was 7.4 ± 4.5 years (range, 1 year to 17.5 years). The right coronary artery (RCA) was the most common origin site for CAF, the left main coronary artery (LMCA) was the second most common origin site whereas the left anterior descending coronary artery (LAD) was the third most common origin site. Catheter angiography showed that right ventricle (RV) was the site of termination for CAF in 23 patients (41.1%) while the CAF drained to the pulmonary artery in 16 patients (28.6%). Transcatheter intervention was performed in ten patients, while CAF were corrected surgically in five patients. Transcatheter intervention was initially attempted in two out of the five surgically-treated patients, but the procedure was unsuccessful. A vascular plug was deployed in six patients, a platinum coil was used in three patients, and a platinum coil with tissue adhesive was placed in one patient using a catheter. Early complications were seen in two patients during transcatheter intervention and in one patient during surgery. There were no instances of death or late complications in patients treated surgically or via transcatheter.
Conclusions:
Coronary artery fistulae are usually asymptomatic, and medical therapy with long term follow up is the first line treatment. Fistulae that cause hemodynamically significant shunting, chamber enlargement, or visible symptoms should be closed at an early age. This study shows that transcatheter closure is a safe treatment option for CAF that may be performed with high success. Also, it should be known that surgery may be performed effectively with low rates of complications. Because complications can develop in treated and untreated patients of all ages, follow-up should occur during the patient`s lifetime.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Aneurysm III: Interprofessional Care


